Evidence map›Paper›PMID 25489735›Full record

ArticlePloS one2014

PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1.

Francesca Fiory, Luca Parrillo, Gregory Alexander Raciti, Federica Zatterale, Cecilia Nigro, Paola Mirra, Roberta Falco, Luca Ulianich, Bruno Di Jeso, Pietro Formisano and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Francesca FioryDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Luca ParrilloDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Gregory Alexander RacitiDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Federica ZatteraleDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Cecilia NigroDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Paola MirraDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Roberta FalcoDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Luca UlianichDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Bruno Di JesoDipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento, Lecce, Italy.
Pietro FormisanoDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Claudia MieleDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Francesco BeguinotDipartimento di Scienze Mediche e Traslazionali dell'Università di Napoli "Federico II", Naples, Italy; URT dell'Istituto di Endocrinologia e Oncologia Sperimentale Gaetano Salvatore, Consiglio Nazionale delle Ricerche, Naples, Italy.
Institute for Experimental Endocrinology and Oncology · ITUniversity of Naples Federico II · ITUniversity of Salento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The small scaffold protein PED/PEA-15 is involved in several different physiologic and pathologic processes, such as cell proliferation and survival, diabetes and cancer. PED/PEA-15 exerts an anti-apoptotic function due to its ability to interfere with both extrinsic and intrinsic apoptotic pathways in different cell types. Recent evidence shows that mice overexpressing PED/PEA-15 present larger pancreatic islets and increased beta-cells mass. In the present work we investigated PED/PEA-15 role in hydrogen peroxide-induced apoptosis in Ins-1E beta-cells. In pancreatic islets isolated from Tg(PED/PEA-15) mice hydrogen peroxide-induced DNA fragmentation was lower compared to WT islets. TUNEL analysis showed that PED/PEA-15 overexpression increases the viability of Ins-1E beta-cells and enhances their resistance to apoptosis induced by hydrogen peroxide exposure. The activity of caspase-3 and the cleavage of PARP-1 were markedly reduced in Ins-1E cells overexpressing PED/PEA-15 (Ins-1E(PED/PEA-15)). In parallel, we observed a decrease of the mRNA levels of pro-apoptotic genes Bcl-xS and Bad. In contrast, the expression of the anti-apoptotic gene Bcl-xL was enhanced. Accordingly, DNA fragmentation was higher in control cells compared to Ins-1E(PED/PEA-15) cells. Interestingly, the preincubation with propranolol, an inhibitor of the pathway of PLD-1, a known interactor of PED/PEA-15, responsible for its deleterious effects on glucose tolerance, abolishes the antiapoptotic effects of PED/PEA-15 overexpression in Ins-1E beta-cells. The same results have been obtained by inhibiting PED/PEA-15 interaction with PLD-1 in Ins-1E(PED/PEA-15). These results show that PED/PEA-15 overexpression is sufficient to block hydrogen peroxide-induced apoptosis in Ins-1E cells through a PLD-1 mediated mechanism.

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsFemaleHeLa CellsHumansHydrogen PeroxideInsulin-Secreting CellsIntracellular Signaling Peptides and ProteinsMaleMicePhospholipase DPhosphoproteinsRatsApoptosis Regulatory ProteinsHydrogen PeroxideIntracellular Signaling Peptides and ProteinsPEA15 protein, humanPhospholipase Dphospholipase D1Phosphoproteins

Identifiers

PMID25489735
PMCPMC4260953
OpenAlexW2021188979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.